Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) in Pulpotomies Primary Teeth
Sponsor: Hadassah Medical Organization
Summary
The objective of this prospective randomized clinical trial is to assess clinically and radiographically, the effect of NeoPutty as a pulp medicament following coronal pulp amputation in human primary molars with carious pulp exposure in comparison to Formocresol (FC).
Official title: Effectiveness of Premixed Bioactive Bioceramic MTA (Neo-Putty®) Versus Formocresol as Dressing Agents in Pulpotomized Primary Molars
Key Details
Gender
All
Age Range
2 Years - 10 Years
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2021-09-01
Completion Date
2026-01-01
Last Updated
2025-06-13
Healthy Volunteers
Yes
Conditions
Interventions
Neo-Putty® as dressing agents in pulpotomized primary molars
Following removal of the coronal pulp with a round bur and hemostasis, the pulp stumps in the study group will be covered with Neo-Putty ® according to the manufacturer's instructions. Neo-Putty will be placed in the prepared cavity, and then covered with Vitrebond® and with a reinforced Zinc Oxide-Eugenol (IRM, Bayer-Leverkussen, Germany). In the control group, a cotton pellet moistened with full-strength FC will be placed for 5 minutes on the amputated pulp, after reaching hemostasis. The pulp stumps will be then covered by IRM
Locations (1)
Hadassah Medical Organization
Jerusalem, Israel